LIVZON PHARMA - An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

does not make any representation about the accuracy or completeness of this announcement and expressly disclaims any liability arising out of or in connection with all or any part of this announcement.

We accept no liability for any loss caused by reliance on such content.

Overseas regulatory announcement

This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

This is to set forth the "Livzon Pharmaceutical Group Co., Ltd." published on the website of the Shenzhen Stock Exchange Ltd. Market Value Management System" is for reference only.

By order of the board of directors

Livzon Pharmaceutical Group Co., Ltd. Livzon Pharmaceutical Group Inc.* company secretary Liu Ning

China, Zhuhai March 24, 2026

As of the date of this announcement, the executive director of the company is Mr. Tang Yanggang (vice chairman); the non-executive director of the company is Mr. Zhu Baoguo. Sheng (Chairman), Mr. Lin Nanqi and Mr. Qiu Qingfeng; the company’s employee director is Ms. Ran Yongmei; and the company’s independence is not

The executive directors are Mr. Bai Hua, Mr. Luo Huiyuan, Ms. Cui Lijie and Ms. Wang Zhiyao.

*Identification only

Livzon Pharmaceutical Group Co., Ltd. Market Value Management System

Chapter 1 General Provisions

Article 1 In order to strengthen the market value management of Livzon Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company"), further

Further standardize the company's market value management behavior, promote the dynamic balance between the company's market value and intrinsic value, and protect the company, investors and other

The legitimate rights and interests of stakeholders shall be determined in accordance with the "Company Law of the People's Republic of China", "Securities Law of the People's Republic of China" and "Listing Corporate Supervision Guidelines No. 10 - Market Value Management" "Shenzhen Stock Exchange Stock Listing Rules" "Shenzhen Stock Exchange

Self-Regulatory Guidelines for Listed Companies No. 1—Standardized Operations of Main Board Listed Companies" and other laws and regulations, departmental rules, and normative

documents and the "Articles of Association of Livzon Pharmaceutical Group Co., Ltd." (hereinafter referred to as the "Articles of Association"), combined with the actual situation of the company,

Develop this system.

Article 2 The term “market value management” as mentioned in this system refers to the company’s efforts to enhance the company’s investment value on the basis of improving company quality. and the ability to return returns to shareholders.

Chapter 2 Basic Principles of Market Value Management

Article 3 Basic principles of market value management: (1) Compliance principles: Companies should strictly abide by relevant laws and regulations, normative documents, self-regulatory rules and

and the Articles of Association and other internal rules and regulations to carry out market value management work.

(2) Systemic principle: The company should follow the principles of systematic thinking and overall advancement, coordinate the company’s various business systems and

Continue to carry out market value management work in a systematic manner.

(3) Scientific principle: The market value management of listed companies has its own rules, and scientific management should be carried out according to these rules. Research and judge the key factors that affect the company's investment value, and carry out market value management based on improving the quality of listed companies.

(4) Principle of normality: The market value growth of listed companies is a continuous and dynamic process, and the company will pay attention to it in a timely manner

Capital market and company stock price dynamics, regular and proactive follow-up to carry out market value management work.

(5) Principle of honesty and trustworthiness: Companies should pay attention to integrity, adhere to the bottom line, assume responsibility, and operate in market value management activities.

Create a healthy and good market ecology.

Chapter 3 Institutions and Responsibilities of Market Value Management

Article 4 The market value management work is led by the board of directors and the operating management participates. The secretary of the board of directors is responsible for the market value management work.

The specific person in charge, the Board Secretariat is the executive agency for market value management work. All departments and subsidiaries of the company should support and coordinate Combined market value management work.

Article 5 The board of directors should attach great importance to the improvement of the company's quality and combine it with the company's current operating performance and the actual development of its main pharmaceutical business.

and future strategic planning, setting long-term goals for the company’s investment value, and focusing on corporate governance, daily operations, innovative research and development, mergers and acquisitions

Fully consider the interests and reasonable returns of all investors when making decisions on major matters such as restructuring and financing, and adhere to steady operations and deep cultivation.

Focus on the main business, avoid blind expansion, and continue to enhance the company’s investment value. The board of directors should pay close attention to the market's reflection of the company's value, and review the company's market performance when it significantly deviates from its intrinsic value.

Carefully analyze and judge possible causes, actively adopt legal and compliant response measures, and promote the company’s investment value to reasonably reflect the company’s economic performance.

Camp quality.

Article 6 The chairman of the board of directors shall actively supervise the board of directors to make relevant resolutions on improving the company’s investment value and carrying out market value management.

Implement implementation, promote the continuous improvement of the company's internal management system to enhance investment value, and coordinate the company's internal and external resources. Adopt legal and compliance measures to promote reasonable investment value of the company and truly reflect the quality of operations and development level.

Article 7 The company’s directors and senior managers shall perform their market value management-related obligations in compliance with laws and regulations, and actively participate in performance evaluations.

Legal investor relations activities such as briefing sessions and investor communication sessions are conducted to enhance investors’ understanding of the company.

Article 8 The secretary to the board of directors is the specific person in charge of the company’s market value management work. The secretary to the board of directors shall do a good job in investor relations.

Department management and information disclosure related work, establish a smooth communication mechanism with investors, and actively collect and analyze the public opinions of all parties in the market. judge the company’s investment value and expectations for the company’s operations, and continue to improve the transparency and accuracy of information disclosure.

The secretary of the board of directors should strengthen public opinion monitoring and analysis, pay close attention to various media reports and market rumors, and discover possible adverse effects on investments.

If the decision-making of investors or the trading price of stocks of listed companies has a greater impact, they must be reported to the board of directors in a timely manner. Listed companies should

When issuing clarification announcements in a timely manner based on the actual situation, legal and compliance measures such as official statements and press conferences can also be adopted.

form to respond. Article 9 The Board Secretariat is the specific execution department for market value management and assists the Board Secretary in information disclosure,

Specific work such as investor relations management, monitoring and analysis.

Article 10 The company’s functional departments and holding subsidiaries shall jointly participate in the specific work of the company’s market value management, and conduct timely and accurate

Accurately and completely provide relevant information required for market value management.

Chapter 4 Main methods of market value management

Article 11 The company always takes value creation as its core, improves operating efficiency and operational capabilities, and comprehensively uses the following methods

Carry out market value management to promote the company's investment value to reasonably reflect the company's quality:

(1) Mergers, acquisitions and reorganizations; (2) Equity incentives and employee stock ownership plans;

(3) Cash dividends;

(4) Investor relations management;

(5) Information disclosure;

(6) Share repurchase;

(7) Other legal and compliant methods. Article 12 The company and its shareholders, directors, senior managers, etc. shall effectively improve their awareness of compliance and shall not

Li Zhong engages in the following behaviors:

(1) Manipulating company information disclosure by controlling the pace of information disclosure, selectively disclosing information, disclosing false information, etc.

ways to mislead or deceive investors;

(2) Through insider trading, leaking inside information, manipulating stock prices, or cooperating with other entities to carry out manipulation, etc. Seek illegal benefits and disrupt the order of the capital market;

(3) Make predictions or promises regarding the trading prices of the company’s securities and their derivatives;

(4) Failure to implement share repurchase through a special repurchase account, failure to increase share holdings through the corresponding real-name account, and increase shareholdings.

Holding or repurchasing violates information disclosure or stock trading rules;

(5) Directly or indirectly disclose confidential project information; (6) Other behaviors that violate laws, administrative regulations, and provisions of the China Securities Regulatory Commission.

Chapter 5 Monitoring and Early Warning Mechanism

Article 13 The company shall establish a market value monitoring and early warning mechanism that meets regulatory requirements, and the secretariat of the board of directors shall be responsible for daily monitoring. The monitoring work adopts a combination of vertical comparison and industry horizontal benchmarking. The core monitoring indicators include: company market value,

Key indicators such as price-to-earnings ratio and price-to-book ratio.

Article 14 When a company experiences a short-term continuous or significant decline in stock price, the following measures should be taken promptly:

(1) Timely analyze the reasons for stock price fluctuations, investigate and verify relevant matters involved, and issue announcements to clarify when necessary

or explain; (2) Strengthen communication with investors and convey the company’s value in a timely manner through investor briefings, road shows and other means;

(3) Formulate, disclose and implement share buybacks under conditions that meet the legal conditions for buybacks and do not affect the company’s daily operations.

purchase plan;

(4) Controlling shareholders, actual controllers, directors, and senior managers may, if they meet the conditions, in accordance with the law.

Formulate, disclose and implement shareholding increase plans or voluntarily extend the share lock-up period, voluntarily terminate the shareholding reduction plan and promise not to reduce Holding shares and other methods to boost market confidence;

(5) Other legal compliance methods permitted by regulatory rules.

Article 15 The short-term continuous or sharp decline in stock prices refers to:

1. The cumulative decline in the closing price of a listed company’s stock reaches 20% within 20 consecutive trading days;

2. The closing price of the listed company’s stock is lower than 50% of the highest closing price of the stock in the last year;

3. Other circumstances specified by the stock exchange.

Chapter 6 Supplementary Provisions

Article 16 The company's board of directors is responsible for formulating, revising and interpreting this system.

Article 17 Matters not covered by this system or inconsistent with relevant national laws, administrative regulations, normative documents and the Articles of Association If consistent, it shall be implemented in accordance with relevant national laws, administrative regulations, normative documents and the Articles of Association.

Article 18 This system shall be implemented from the date of review and approval by the company's board of directors.